Pharma · Public company · Princeton, NJ, US

Bristol Myers Squibb Co

Ticker BMY · SEC CIK 0000014272

Track this companyFree. Adds Bristol Myers Squibb Co to your Dealase workspace and tells you when its record changes.

Clinical trials2525 recruiting or active

Pipeline programs44From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline44

AtezolizumabPhase 3 · Extensive-Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
BMS-986489 (Atigotatug+Nivolumab)Phase 3 · Extensive-Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
CapoxPhase 3 · Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 3 · Extensive-Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
CisplatinPhase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
DurvalumabPhase 3 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
EtoposidePhase 3 · Extensive-Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
FolfoxPhase 3 · Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Iza-brenPhase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
KarX-ECPhase 3 · Irritability Associated With Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
KarXTPhase 3 · Irritability Associated With Autism Spectrum DisorderClinicalTrials.gov · fetched Nov 12, 2026
KarXTPhase 3 · Bipolar Disorder Type I With Mania or Mania With Mixed FeaturesClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 3 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 3 · Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
OsimertinibPhase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 3 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PumitamigPhase 3 · Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
PumitamigPhase 3 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
RelatlimabPhase 3 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Xanomeline Enteric CapsulePhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Xanomeline Enteric CapsulePhase 3 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Xanomeline/Trospium ChloridePhase 3 · ManiaClinicalTrials.gov · fetched Nov 12, 2026
Xanomeline/Trospium Chloride CapsulePhase 3 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Xanomeline/Trospium Chloride CapsulePhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
BMS-986446Phase 2 · Alzheimer Disease, Early OnsetClinicalTrials.gov · fetched Nov 12, 2026
CabozantinibPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
DaraxonrasibPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
IpilimumabPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
NavlimetostatPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Nivolumab + RelatlimabPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PumitamigPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
RelatlimabPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
TemozolomidePhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
TrametinibPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
[14C]NavlimetostatPhase 1 · Healthy Female ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
CC-122Phase 1 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
DexamethasonePhase 1 · Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
NavlimetostatPhase 1 · Healthy Female ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Xanomeline/trospium chlorideSchizophreniaClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large B-Cell LymphomaPHASE2 · NOT_YET_RECRUITING · started Apr 29, 2027ClinicalTrials.gov NCT07917832 · fetched Nov 12, 2026
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS TrialNA · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07615764 · fetched Nov 12, 2026
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With AutismPHASE3 · RECRUITING · started Oct 6, 2026ClinicalTrials.gov NCT07284745 · fetched Nov 12, 2026
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum DisorderPHASE3 · RECRUITING · started Oct 6, 2026ClinicalTrials.gov NCT07285798 · fetched Nov 12, 2026
A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female ParticipantsPHASE1 · RECRUITING · started Sep 29, 2026ClinicalTrials.gov NCT07777133 · fetched Nov 12, 2026
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)PHASE3 · RECRUITING · started Sep 8, 2026ClinicalTrials.gov NCT07680790 · fetched Nov 12, 2026
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)PHASE2 · RECRUITING · started Jul 27, 2026ClinicalTrials.gov NCT07492680 · fetched Nov 12, 2026
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)PHASE3 · RECRUITING · started Mar 16, 2026ClinicalTrials.gov NCT07361497 · fetched Nov 12, 2026
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)PHASE2_PHASE3 · RECRUITING · started Mar 13, 2026ClinicalTrials.gov NCT07221149 · fetched Nov 12, 2026
A Study to Evaluate the Effect of KarXT on Urological SafetyPHASE4 · RECRUITING · started Jan 20, 2026ClinicalTrials.gov NCT07221877 · fetched Nov 12, 2026
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or LamotriginePHASE3 · RECRUITING · started Oct 8, 2025ClinicalTrials.gov NCT07140913 · fetched Nov 12, 2026
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseasePHASE3 · RECRUITING · started Jul 16, 2025ClinicalTrials.gov NCT07011745 · fetched Nov 12, 2026
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)PHASE3 · RECRUITING · started Jul 10, 2025ClinicalTrials.gov NCT07011732 · fetched Nov 12, 2026
Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)ACTIVE_NOT_RECRUITING · started Jul 1, 2025ClinicalTrials.gov NCT06870617 · fetched Nov 12, 2026
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)PHASE3 · RECRUITING · started Jun 13, 2025ClinicalTrials.gov NCT06951711 · fetched Nov 12, 2026
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).PHASE3 · RECRUITING · started Feb 25, 2025ClinicalTrials.gov NCT06646276 · fetched Nov 12, 2026
ELEVATE-MM: Elotuzumab, Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple MyelomaPHASE1 · RECRUITING · started Nov 1, 2024ClinicalTrials.gov NCT06518551 · fetched Nov 12, 2026
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%PHASE3 · RECRUITING · started Oct 7, 2024ClinicalTrials.gov NCT06561386 · fetched Nov 12, 2026
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Mar 20, 2024ClinicalTrials.gov NCT06268886 · fetched Nov 12, 2026
A Study of Milvexian Versus Apixaban in Participants With Atrial FibrillationPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 11, 2023ClinicalTrials.gov NCT05757869 · fetched Nov 12, 2026
A Rollover Study of CC-122PHASE1 · ACTIVE_NOT_RECRUITING · started Apr 11, 2023ClinicalTrials.gov NCT05688475 · fetched Nov 12, 2026
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 2, 2023ClinicalTrials.gov NCT05502315 · fetched Nov 12, 2026
Pan Tumor Rollover StudyPHASE2 · RECRUITING · started Aug 9, 2019ClinicalTrials.gov NCT03899155 · fetched Nov 12, 2026
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin LymphomaPHASE1_PHASE2 · RECRUITING · started Sep 13, 2018ClinicalTrials.gov NCT03681561 · fetched Nov 12, 2026
National Pregnancy Registry for Psychiatric MedicationsRECRUITING · started Nov 1, 2008ClinicalTrials.gov NCT01246765 · fetched Nov 12, 2026

SEC filings12

10-Q · 10-QSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Jul 30, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jul 30, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed May 8, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
10-K · 10-KSEC EDGAR · filed Feb 11, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Feb 5, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Jan 12, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Nov 18, 2025 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Nov 10, 2025 · fetched Nov 12, 2026